Public-registry site landscape for NCT06825559, a Cholestatic Liver Disease study sponsored by Zydus Therapeutics Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06825559 (registry record) |
| Sponsor | Zydus Therapeutics Inc. |
| Condition(s) | Cholestatic Liver Disease |
| Phase | PHASE1 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT06825559 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →